Scarica l'app Stockscreener
29.60
0.54%
0.16
Dopo l'orario di chiusura:
29.60
Mbx Biosciences Inc Borsa (MBX) Ultime notizie
MBX Biosciences (NASDAQ: MBX) director awarded RSUs and 74,249 stock options - Stock Titan
MBX (MBX) Rule 144: Bartram sold 21,484 shares; Fidelity lists 5,000 - Stock Titan
Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX), Cytokinetics (CYTK) and Crescent Biopharma (CBIO) - The Globe and Mail
MBX SEC FilingsMBX Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
BlackRock (MBX) files Schedule 13G/A showing 4.8% ownership - Stock Titan
MBX Biosciences stock down on pricing upsized public offering at $18.00 per share - MSN
Wall Street Analysts See a 280.14% Upside in MBX Biosciences, Inc. (MBX): Can the Stock Really Move This High? - MSN
A Look At MBX Biosciences (MBX) Valuation After Its Recent Share Price Move - Sahm
MBX Biosciences (NASDAQ:MBX) Amid Evolving Biotech Trends - Kalkine Media
MBX Biosciences (NASDAQ:MBX) Trading Down 6.3%Should You Sell? - MarketBeat
Truist reiterates Buy on MBX Biosciences stock ahead of trial data By Investing.com - Investing.com South Africa
Truist reiterates Buy on MBX Biosciences stock ahead of trial data - Investing.com Australia
MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio - The Manila Times
MBX to detail obesity drug pipeline at May 11 online, in-person event - Stock Titan
MBX Biosciences Inc. beats EPS estimates by 20.4%Community Driven Stock Picks - Xã Châu Thành
MBX Biosciences (MBX) Stock Outlook | MBX Biosciences Inc. beats EPS estimates by 20.4%Dividend Growth - Xã Vĩnh Công
MBX Biosciences, Inc. ($MBX) CEO 2025 Pay Revealed - Quiver Quantitative
Proposed sale of 10,423 MBX shares (NASDAQ: MBX) reported - Stock Titan
Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase - The Motley Fool
Aaron Wealth Advisors Increases MBX Biosciences Stake to $37 Million - HarianBasis.co
[ARS] MBX Biosciences, Inc. SEC Filing - Stock Titan
MBX Biosciences (NASDAQ: MBX) plans 2026 virtual meeting and auditor vote - Stock Titan
MBX Biosciences (MBX) director receives capped 2025 stock option grant - Stock Titan
MBX Biosciences (MBX) grants 33,751 stock options to director Hoerter - Stock Titan
Aaron Wealth Advisors Increases Stake in MBX Biosciences - Intellectia AI
MBX Biosciences, Inc. (NASDAQ:MBX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
MBX Biosciences, Inc. (NASDAQ:MBX) Short Interest Up 20.4% in March - MarketBeat
Stifel reiterates Buy on MBX Biosciences stock, keeps $50 target By Investing.com - Investing.com Australia
Stifel reiterates Buy on MBX Biosciences stock, keeps $50 target - Investing.com
Is MBX Biosciences Inc stock influenced by commodity pricesWeekly Earnings Recap & Daily Growth Stock Tips - baoquankhu1.vn
Is MBX Biosciences (MBX) Stock cheap compared to earnings | Price at $31.64, Up 2.08%Fast Rising Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Goldman Sachs initiates coverage of MBX Biosciences (MBX) with sell recommendation - MSN
MBX Biosciences (NASDAQ:MBX) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
MBX Biosciences, Inc. focuses on science-led innovation to transform endocrine and metabolic disease treatment - Traders Union
MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Institution Moves: Is MBX Biosciences Inc part of any ETF2026 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn
Is MBX Biosciences (MBX) Stock Rebounding | Price at $31.30, Down 5.12%Trending Buy Opportunities - Cổng thông tin điện tử tỉnh Tây Ninh
Does MBX (MBX) Options-Driven Breakout Reveal Deeper Shifts In Its Investment Narrative? - Yahoo Finance
MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Sahm
MBX Biosciences (MBX) Is Up 16.6% After Analyst Initiation And Leadership Award News Has The Bull Case Changed? - Sahm
MBX Biosciences Approves Equity-Based Inducement Grant for New Employee Under Nasdaq Rule - geneonline.com
MBX Biosciences Reports Inducement Grant - National Today
Lifesci Capital Weighs in on MBX Biosciences Q1 Earnings - MarketBeat
New MBX business chief gets 130,000 stock options at $32.29 - Stock Titan
MBX Biosciences (NASDAQ:MBX) Upgraded at Lifesci Capital - MarketBeat
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):